TeleTrader 2/12/2024 Earnings preview: Robinhood, Coinbase and more
GlobeNewswire 2/8/2024 Zymeworks Announces Appointment of Dr. Alessandra Cesano to its Board of Directors
GlobeNewswire 1/4/2024 Stran & Company Appoints Ian Thomas Wall as Chief Information Officer
GlobeNewswire 12/19/2023 Centralized Marketing Authorizations of Generic Versions of TECFIDERA® are Revoked by the European C...
GlobeNewswire 12/15/2023 CHMP Issues Positive Opinion for Biogen’s SKYCLARYS® (omaveloxolone), the First Therapy to Treat Fri...
GlobeNewswire 12/14/2023 ZURZUVAE™ (zuranolone) CIV, a Landmark Oral Treatment for Women with Postpartum Depression (PPD), is...
TeleTrader 11/8/2023 Biogen's Q3 revenue up 3% to $2.5B
GlobeNewswire 11/6/2023 Biogen Appoints Monish Patolawala to its Board of Directors
GlobeNewswire 10/25/2023 Eisai Presents New LEQEMBI® (lecanemab-irmb) Investigational Subcutaneous Formulation Interim Study ...
GlobeNewswire 10/25/2023 New Data from Biogen’s Investigational Antisense Oligonucleotide (ASO) Targeting Tau Shows Promise f...
GlobeNewswire 10/19/2023 Biogen to Present New Data at the Clinical Trials on Alzheimer’s Disease (CTAD) 2023 Meeting
GlobeNewswire 9/29/2023 FDA Approves Biogen’s TOFIDENCE™ (tocilizumab-bavi), a Biosimilar Referencing ACTEMRA®
GlobeNewswire 9/26/2023 Biogen Completes Acquisition of Reata Pharmaceuticals
TeleTrader 9/25/2023 Japan approves Eisai-Biogen Alzheimer's drug
GlobeNewswire 9/25/2023 LEQEMBI® Intravenous Infusion (Lecanemab) Approved for the Treatment of Alzheimer’s Disease in Japan
GlobeNewswire 9/6/2023 Biogen Appoints Jane Grogan as Head of Research
GlobeNewswire 8/28/2023 Elicio Therapeutics Announces Appointment of Megan Filoon as General Counsel and Dr. Thian Kheoh as ...
TeleTrader 7/28/2023 Biogen to acquire Reata for $7.3 billion in cash
TeleTrader 7/25/2023 Biogen's revenue in Q2 at $2.4 billion
TeleTrader 7/6/2023 FDA approves Biogen-Eisai Alzheimer drug Leqembi
TeleTrader 4/25/2023 FDA authorizes use of Biogen's ALS treatment
TeleTrader 4/25/2023 Biogen's Q1 total revenue down by 3% to $2.5 billion
TeleTrader 3/6/2023 FDA accepts Alzheimer drug for traditional approval path
TeleTrader 1/6/2023 FDA approves drug for early Alzheimer's treatment
TeleTrader 11/28/2022 Wall Street extends losses on rate talks, China unrest